sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide

C94H103BrI3N20NaO10Zn — CID 161160102

IUPACsodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
SMILESCC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)NCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br
InChIInChI=1S/C23H24N6O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-14(2)29-22-8-17(23(30)27-12-18-11-24-16(4)10-25-18)7-19(20(22)13-28-29)21-6-5-15(3)9-26-21;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5-11,13-14H,12H2,1-4H3,(H,27,30);5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2
InChIKeyWKNCBEPSKGZOIV-UHFFFAOYSA-L
MW2221.98 g/mol
LogP17.37
Rot. Bonds15

About sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide

sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide (PubChem CID 161160102) has the molecular formula C94H103BrI3N20NaO10Zn and a molecular weight of 2221.98 g/mol. Its IUPAC name is sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide.

Molecular Properties

Compound Namesodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
PubChem CID161160102
Molecular FormulaC94H103BrI3N20NaO10Zn
Molecular Weight2221.98 g/mol
Exact Mass2218.37
IUPAC Namesodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
SMILESCC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)NCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br
InChIInChI=1S/C23H24N6O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-14(2)29-22-8-17(23(30)27-12-18-11-24-16(4)10-25-18)7-19(20(22)13-28-29)21-6-5-15(3)9-26-21;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5-11,13-14H,12H2,1-4H3,(H,27,30);5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2
InChIKeyWKNCBEPSKGZOIV-UHFFFAOYSA-L
XLogP17.37
TPSA404.40 Ų
H-Bond Donors4
H-Bond Acceptors27
Rotatable Bonds15
Heavy Atoms130
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002221.98
LogP ≤ 517.37
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

8-tert-butyl-6-ethenylisoquinoline;8-tert-butyl-6-ethylisoquinoline;3-tert-butyl-1H-indole;(8-tert-butylisoquinolin-6-yl)methanol;4-(8-tert-butylisoquinolin-3-yl)-1-methylpyrazole-3-carbonitrile;3-tert-butyl-1-methylindole;8-tert-butyl-6-methylisoquinoline;8-tert-butyl-5-methyl-3-(1-methylpyrazol-4-yl)isoquinoline;5-tert-butyl-2-(1-methylpyrazol-4-yl)-3,4-dihydroisoquinolin-1-one;3-tert-butyl-6-(1-methylpyrazol-4-yl)-1H-indole;2-methyl-5-(1-methylpyrazol-4-yl)-1-propan-2-ylpyrrolo[2,3-c]pyridine
CID 157140414
sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;3-(5-methylpyrazin-2-yl)-1-[4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazol-6-yl]propan-1-one;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide
CID 157453359
1,2-Dimethyl-3-propan-2-ylindole-5-carboxylic acid;1,5-dimethyl-7-propan-2-ylindole-2-carboxylic acid;1-[4-[(3-ethyl-1-methylindol-5-yl)methyl]piperazin-1-yl]ethanone;1-methyl-5-[(4-methylpiperazin-1-yl)methyl]-3-propan-2-ylindole;1-methyl-3-propan-2-ylindazole-4-carboxylic acid;1-methyl-3-propan-2-ylindole-6-carboxamide;bis(7-propan-2-yl-1-(pyridin-2-ylmethyl)indole-2-carboxylic acid)
CID 158234166
bis(4-[(E)-2-(4-methoxycarbonylphenyl)ethenyl]benzoic acid);methyl 3-(1H-indol-3-yl)-2-[[2-[4-[[3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-yl]carbamoyl]-2-pyridinyl]pyridine-4-carbonyl]amino]propanoate;bis(2-pyridin-2-ylpyridine);ruthenium
CID 158480461
4-[5-(4-fluorophenyl)-1-methyl-6-(oxan-4-yl)pyrrolo[2,3-f]indazol-7-yl]benzoic acid;4-[5-(2-methyl-4-pyridinyl)-6-(oxan-4-yl)-1H-pyrrolo[3,2-f]indazol-7-yl]benzamide;4-[5-(2-methyl-4-pyridinyl)-6-(oxan-4-yl)-1H-pyrrolo[3,2-f]indazol-7-yl]-N-(5-oxopyrrolidin-3-yl)benzamide
CID 158816015
sodium;methane;methyl 4-(5-methyl-2-pyridinyl)-1H-indazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxamide;4-(5-methyl-2-pyridinyl)-1-phenylindazole-6-carboxylic acid;hydroxide
CID 158824967
ethyl (E)-3-(4-iodophenyl)prop-2-enoate;ethyl (E)-3-[4-[3-(4-pyrrolidin-1-ylpiperidine-1-carbonyl)indazol-1-yl]phenyl]prop-2-enoate;1H-indazole-3-carboxylic acid;1H-indazol-3-yl-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone;(E)-N-(pyridin-3-ylmethyl)-3-[4-[3-(4-pyrrolidin-1-ylpiperidine-1-carbonyl)indazol-1-yl]phenyl]prop-2-enamide
CID 158826965
1,2-diiodo-2-methylpropane;N,5-dipyridin-3-yl-1H-indazole-3-carboxamide;iodoethane;2-iodo-2-methanidylpropane;2-iodo-2-methylpropane;5-iodo-1-(oxan-2-yl)indazole-3-carbaldehyde;1-(oxan-2-yl)-N,5-dipyridin-3-ylindazole-3-carboxamide;1-(oxan-2-yl)-5-pyridin-3-ylindazole-3-carbaldehyde;1-(oxan-2-yl)-5-pyridin-3-ylindazole-3-carboxylic acid;pyridin-3-amine;pyridin-3-ylboronic acid;1,1,2-triiodo-2-methylpropane;bis(vanadium)
CID 158995778
7-(1,3-dimethylpyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;methyl 3-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrrole-2-carboxylate;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyrazol-1-yl]ethanol;7-(2H-triazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine
CID 159270967
sodium;(2S)-2-aminopropan-1-ol;bromozinc(1+);(3R)-4-hydroxy-3-methyl-1-[3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazol-5-yl]butan-1-one;1-iodo-2-methylpropane;methyl 7-iodo-3H-benzimidazole-5-carboxylate;methyl 4-iodo-1-(2-methylpropyl)indazole-6-carboxylate;methyl 3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazole-5-carboxylate;3-(2-methylpropyl)-7-(5-methyl-2-pyridinyl)benzimidazole-5-carboxylic acid;5-methyl-2H-pyridin-2-ide;hydroxide
CID 159697247
tert-butyl 3-[7-(4-methoxycarbonylphenyl)-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidine-1-carboxylate;tert-butyl 3-[7-[4-(2-pyridin-2-ylacetyl)phenyl]-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidine-1-carboxylate;4-[5-[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]-1H-pyrazolo[3,4-c]pyridin-7-yl]benzoic acid;1-[3-[7-[4-(2-pyridin-2-ylacetyl)phenyl]-1H-pyrazolo[3,4-c]pyridin-5-yl]pyrrolidin-1-yl]prop-2-en-1-one;2-pyridin-2-yl-1-[4-(5-pyrrolidin-3-yl-1H-pyrazolo[3,4-c]pyridin-7-yl)phenyl]ethanone
CID 159824817
5,5-dimethyl-4,10-dihydro-1H-pyrazolo[5,4-a]carbazole-7-carboxylic acid;5,5-dimethyl-N-pyridin-3-yl-4,10-dihydro-1H-pyrazolo[5,4-a]carbazole-7-carboxamide;pyridin-3-amine
CID 160130984

Frequently Asked Questions

What is the IUPAC name of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The IUPAC name of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide (CID 161160102) is sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide.
What is the SMILES notation for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The canonical SMILES for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide is CC(C)I.COC(=O)c1cc(-c2ccc(C)cn2)c2cnn(C(C)C)c2c1.COC(=O)c1cc(I)c2cn[nH]c2c1.COC(=O)c1cc(I)c2cnn(C(C)C)c2c1.Cc1cc[c-]nc1.Cc1ccc(-c2cc(C(=O)NCc3cnc(C)cn3)cc3c2cnn3C(C)C)nc1.Cc1ccc(-c2cc(C(=O)O)cc3c2cnn3C(C)C)nc1.Cc1cnc(CN)cn1.[Na+].[OH-].[Zn+]Br.
What is the InChIKey of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
The InChIKey is WKNCBEPSKGZOIV-UHFFFAOYSA-L. The full InChI is InChI=1S/C23H24N6O.C18H19N3O2.C17H17N3O2.C12H13IN2O2.C9H7IN2O2.C6H9N3.C6H6N.C3H7I.BrH.Na.H2O.Zn/c1-14(2)29-22-8-17(23(30)27-12-18-11-24-16(4)10-25-18)7-19(20(22)13-28-29)21-6-5-15(3)9-26-21;1-11(2)21-17-8-13(18(22)23-4)7-14(15(17)10-20-21)16-6-5-12(3)9-19-16;1-10(2)20-16-7-12(17(21)22)6-13(14(16)9-19-20)15-5-4-11(3)8-18-15;1-7(2)15-11-5-8(12(16)17-3)4-10(13)9(11)6-14-15;1-14-9(13)5-2-7(10)6-4-11-12-8(6)3-5;1-5-3-9-6(2-7)4-8-5;1-6-3-2-4-7-5-6;1-3(2)4;;;;/h5-11,13-14H,12H2,1-4H3,(H,27,30);5-11H,1-4H3;4-10H,1-3H3,(H,21,22);4-7H,1-3H3;2-4H,1H3,(H,11,12);3-4H,2,7H2,1H3;2-3,5H,1H3;3H,1-2H3;1H;;1H2;/q;;;;;;-1;;;+1;;+2/p-2.
What are the key properties of sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide?
sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide has a molecular weight of 2221.98 g/mol, XLogP of 17.37, 15 rotatable bonds, 4 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;bromozinc(1+);2-iodopropane;methyl 4-iodo-1H-indazole-6-carboxylate;methyl 4-iodo-1-propan-2-ylindazole-6-carboxylate;methyl 4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylate;(5-methylpyrazin-2-yl)methanamine;N-[(5-methylpyrazin-2-yl)methyl]-4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxamide;5-methyl-2H-pyridin-2-ide;4-(5-methyl-2-pyridinyl)-1-propan-2-ylindazole-6-carboxylic acid;hydroxide is sourced from PubChem (CID 161160102), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).